U.S. Food and Drug Administration (FDA) · United States
FDA Direct-to-Consumer Prescription Drug Ads
Requires DTC Rx ads to present the major risk statement clearly, conspicuously and neutrally, to provide adequate provision for full prescribing information in broadcast, and to include a brief summary in print.
21 U.S.C. 352(n); 21 CFR 202.1(e)(1), (e)(6)
What is FDA Direct-to-Consumer Prescription Drug Ads?
Requires DTC Rx ads to present the major risk statement clearly, conspicuously and neutrally, to provide adequate provision for full prescribing information in broadcast, and to include a brief summary in print. Apply to U.S. DTC prescription drug ads on TV, radio, streaming video, print and digital.
general_audience, general_adults_18plus, customers · Prescription Drug · pharma
Where does this rule apply?
United States
Which marketing channels are covered?
all_channels
When does this rule take effect?
2026-05-10
What does this rule require?
Requires DTC Rx ads to present the major risk statement clearly, conspicuously and neutrally, to provide adequate provision for full prescribing information in broadcast, and to include a brief summary in print.
How can marketing teams comply?
Apply to U.S. DTC prescription drug ads on TV, radio, streaming video, print and digital.
What is FDA Direct-to-Consumer Prescription Drug Ads?
Requires DTC Rx ads to present the major risk statement clearly, conspicuously and neutrally, to provide adequate provision for full prescribing information in broadcast, and to include a brief summary in print.
Who does this rule apply to?
general_audience, general_adults_18plus, customers · Prescription Drug · pharma
Tobacco and nicotine ads must carry the required health warnings (20% of ad area for ENDS, cigars and smokeless), may not make light, mild or reduced-risk claims without an FDA modified-risk order, and may not offer free samples or appeal to youth.
FDA's food labeling rules require a Nutrition Facts panel and other label elements and restrict nutrient and 'healthy' claims to foods meeting FDA criteria; the amended 'healthy' definition is effective April 28, 2025 with compliance required by Feb. 25, 2028.
Supplements, cosmetics, foods and CBD products become unapproved drugs if their marketing claims to diagnose, treat, cure, mitigate or prevent disease, and cosmetics also may not claim to affect body structure or function.
OTC external drug products covered by 21 CFR 358 (warts, corns and calluses, ingrown toenails, lice, dandruff, seborrheic dermatitis, psoriasis) may only claim the uses and actives in their monograph.
FDA food additive rules require additives to be approved or GRAS, and labeling rules require certified colors and preservatives to be declared properly; 'no artificial' or 'no preservative' claims must match the ingredient list.
Food and supplement labels may link a substance to reduced disease risk only through FDA-authorized or qualified health claims, in the required form, and only on foods meeting nutrient eligibility; disease treatment claims are not allowed.
Request a free compliance scan of your homepage and book a time with Warrant.